What evidence‑based strategies can be used to prevent age‑related macular degeneration?

How to Prevent Age-Related Macular Degeneration

The only proven effective preventive measures for AMD are smoking cessation and AREDS2 supplementation in individuals with intermediate AMD or advanced AMD in one eye. 1, 2

Mandatory Smoking Cessation

• Cigarette smoking is the single most critical modifiable risk factor for AMD, with current smokers facing 2-3 times higher risk and progression proportional to pack-years smoked. 1
• Smoking cessation counseling must occur at every clinical encounter, as this is the only modifiable risk factor proven to reduce AMD progression. 1, 3
• Former smokers remain at elevated risk, making immediate cessation essential even after AMD diagnosis. 1

AREDS2 Supplementation for At-Risk Individuals

AREDS2 supplementation should be initiated immediately in patients with intermediate AMD (large drusen ≥125 μm with RPE changes) or advanced AMD in one eye, as it reduces progression risk by up to 36% over 10 years. 1, 3

Who Should Take AREDS2

• Patients with bilateral large drusen (≥125 μm) with RPE clumping or atrophy represent high-risk features requiring supplementation. 1
• Individuals with advanced AMD in one eye and large drusen in the fellow eye are the highest risk group and must receive AREDS2. 1
• AREDS2 is not indicated for primary prevention in individuals without AMD or with only small drusen, as the evidence supports use only in intermediate or advanced disease. 1, 4

AREDS2 Formulation Specifics

• The evidence-based formulation includes: vitamin C, vitamin E, zinc 25 mg, copper, lutein 10 mg, and zeaxanthin 2 mg. 1, 3
• For current or former smokers, beta-carotene must be excluded due to an 18% increased cumulative incidence of lung cancer (relative risk 1.28). 1
• Lutein and zeaxanthin serve as appropriate carotenoid substitutes for beta-carotene, particularly in smokers. 1, 3
• The 25 mg zinc dose provides equivalent efficacy to 80 mg while reducing genitourinary hospitalizations. 1
• Copper is included solely to prevent copper-deficiency anemia from zinc supplementation. 1

Important Safety Considerations

• Coordinate with the patient's primary care physician before initiating long-term AREDS2 supplementation due to potential adverse effects, particularly increased genitourinary conditions with zinc. 1
• AREDS2 supplements contain no iron, and additional iron supplementation is unnecessary and potentially harmful in AMD. 5

Dietary and Lifestyle Modifications

Diet Quality

• Adherence to a Mediterranean diet rich in green leafy vegetables, fish, legumes, whole grains, and nuts is associated with lower risk of both early and late AMD. 6, 7
• High dietary intake of foods rich in lutein, zeaxanthin, and omega-3 fatty acids reduces progression risk. 6
• Low intake of green leafy vegetables and fish increases AMD risk. 6

Weight Management and Physical Activity

• Obesity and elevated BMI correlate with higher AMD progression risk, with unhealthy BMI contributing to 3- to 5-fold increased incidence in genetically susceptible populations. 1, 6
• Physical inactivity has been associated with increased risk of early AMD and progression. 7
• High caloric intake independently increases AMD risk. 6

Cardiovascular Risk Factor Control

• Cardiovascular disease, hypertension, and hyperlipidemia correlate with higher AMD progression risk. 1, 7
• Diabetes has been associated with increased risk of AMD development. 7
• Managing these systemic conditions may reduce AMD risk, though direct causality remains under investigation. 7

Sunlight Exposure

• Prolonged sunlight exposure has been associated with increased AMD risk. 7
• While protective eyewear is commonly recommended, the strength of evidence for sunglasses in AMD prevention remains limited. 2

Patient Education and Monitoring

• Provide an Amsler grid for daily home monitoring of metamorphopsia, with instruction to return immediately for any new visual symptoms such as distortion or central vision changes. 1
• Patients must understand that AREDS2 slows progression but does not restore lost vision or prevent all cases of advanced AMD. 1
• Education on the 56-60% reduction in incident advanced AMD achievable through adopting an ideal health-promoting lifestyle profile (no smoking, healthy BMI, appropriate caloric intake, high intake of lutein/zeaxanthin and omega-3 rich foods) is essential. 6

What Does NOT Prevent AMD

• Vitamin E supplementation alone showed no benefit in preventing AMD progression (RR 1.36,95% CI 0.31 to 6.05). 4
• Lutein/zeaxanthin supplementation alone (without the full AREDS2 formulation) in individuals already taking AREDS showed minimal additional benefit. 4
• There is no evidence supporting peptide-based therapies, and patients should be counseled that such supplements lack evidence and may delay effective treatment. 1
• Iron supplementation offers no benefit for AMD and may increase risk of retinal hemorrhage or progression; it should only be prescribed when iron-deficiency anemia is confirmed by laboratory testing. 5

Common Pitfalls to Avoid

• Do not recommend AREDS2 for primary prevention in individuals without AMD, as the evidence supports use only in intermediate or advanced disease. 1, 4
• Never prescribe beta-carotene-containing formulations to current or former smokers due to documented lung cancer risk. 1
• Avoid 80 mg zinc formulations when 25 mg provides equivalent efficacy with better safety profile. 1
• Do not delay smoking cessation counseling or assume patients have already been advised; this must occur at every visit. 1

Population Attributable Risk

• In never smokers with high genetic risk, adopting an ideal health-promoting lifestyle profile could prevent 56% of incident advanced AMD. 6
• In ever smokers with high genetic risk, this percentage increases to 60%. 6
• These data underscore that even in genetically susceptible populations, modifiable lifestyle factors account for the majority of preventable AMD progression. 6